Dr. Xia Song 宋霞
Chief Physician
Department of Respiratory Medicine, Shanxi Cancer Hospital, Taiyuan
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Diagnosis and medical management of primary and secondary chest tumors, with a focus on lung cancer and breast cancer.
Dr. Song is Chief Physician and Department Head at Shanxi Cancer Hospital. Graduating in 1986 from Bethune Medical University, Dr. Song has practiced medical oncology since then, including research training in Sweden (1999–2000). Research interests include clinical studies in medical oncology; work on closed thoracic drainage received a Second Prize for Provincial Scientific and Technological Progress.
Professional roles
- Council Member, Shanxi Medical Association
- Vice Chair, Lung Cancer Professional Committee, Shanxi Anti-Cancer Association
- Member, American Society of Clinical Oncology (ASCO)
- Member, European Society for Medical Oncology (ESMO)
Name order: in Chinese the family name comes first (Song Xia). Papers usually list the name as Xia Song or Song X.
Selected publications
41 papers on PubMed matched by name and affiliation; 8 as first or senior author since 2016. Most recent first- or senior-author papers:
- Zhongguo Fei Ai Za Zhi, 2022 (senior author): [Research Advances of Immunotherapy of Exosome PD-L1 in Non-small Cell Lung Cancer]. PubMed 36172735
- Zhongguo Fei Ai Za Zhi, 2022 (senior author): [Research Progress of Acquired Resistance Mediated by MET Amplification in Advanced Non-small Cell Lung Cancer]. PubMed 36002199
- Zhongguo Fei Ai Za Zhi, 2022 (senior author): [Research Advances of EGFR-TP53 Co-mutation in Advanced Non-small Cell Lung Cancer]. PubMed 35340160
- Front Oncol, 2020 (senior author): Osimertinib Resistance With a Novel EGFR L858R/A859S/Y891D Triple Mutation in a Patient With Non-Small Cell Lung Cancer: A Case Report. PubMed 33324543
- Transl Lung Cancer Res, 2020 (senior author): Long-term survival with targeted therapy in an advanced non-small cell lung cancer patient based on genetic profiling. PubMed 32420078
- Zhongguo Fei Ai Za Zhi, 2016 (senior author): [Progress in the Treatment of Non-small Cell Lung Cancer with BRAF Inhibitors]. PubMed 27760604
- Zhongguo Fei Ai Za Zhi, 2016 (senior author): [Advances in Bevacizumab Therapy for Non-small Cell Lung Cancer with Brain Metastases]. PubMed 27561800
- Asia Pac J Clin Oncol, 2016 (senior author): Serum protein profiles of patients with lung cancer of different histological types. PubMed 26668125
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that the papers match this doctor's specialty; this check is automatic.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion